Blood Collection Market – By Product Type, By Method, By Application, By End Use – Global Forecast, 2025 – 2034

Blood Collection Market Size

The global blood collection market was estimated at USD 10.2 billion in 2024. The market is expected to grow from USD 10.8 billion in 2025 to USD 18.3 billion in 2034, growing at a CAGR of 6.1%. The growth of the global market is largely influenced by the growing prevalence of chronic and infectious diseases such as diabetes, cancer, cardiovascular disease, tuberculosis, and HIV, among others, along with the growing technological advancements, increasing number of surgical procedures, and rising geriatric population base, which further fuel the growth of the market.

A blood collection device is a medical tool which is designed to draw blood samples safely and efficiently for diagnostic testing, transfusions, or research purposes. These devices play a vital role in clinical settings and are further used across hospitals, laboratories, and blood banks. Major players in the blood collection industry include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, and McKesson Corporation. The market primarily focuses on devices such as needles and syringes, which is estimated to reach USD 49.1 billion by 2032, vacuum blood collection tubes, lancet, and blood collection sets, which are designed to ensure patient comfort, sample integrity, and safety for healthcare professionals.
 

The market increased from USD 8.8 billion in 2021 to USD 9.7 billion in 2023, registering a CAGR of 6.1% during this period. This growth was driven by the rising demand for diagnostic testing, growing awareness of preventive healthcare, and expanding healthcare infrastructure globally. The continuous innovations in blood collection technologies, such as safety-engineered devices and vacuum-based systems, which enhances patient comfort and reduce the risk of needlestick injuries. Additionally, the rising emphasis on accurate and efficient sample collection in clinical laboratories and hospitals has further strengthened the market’s growth.
 

The increasing prevalence of chronic diseases further is accelerating the growth of the market. For instance, in 2021, as per the data from the World Health Organization (WHO), non-communicable disease was responsible for 43 million deaths worldwide. Among the million, vascular disease was responsible for at least 19 million deaths, followed by cancer with 10 million and chronic respiratory diseases with 4 million. Moreover, as per the report from the International Diabetes Federation in 2024, 589 million individuals were living with diabetes, with projections indicating that this number will rise to 853 million by 2050. Therefore, the growing number of patients with these chronic conditions’ requires accurate and early disease diagnosis, where blood collection plays an important role. Blood samples enable comprehensive diagnostic insights, facilitating timely intervention and personalized treatment strategies. Thus, this growing demand for diagnostic tools is expected to significantly propel the growth of the market.
 

Moreover, the rise in surgical procedures across the world has emerged as a key catalyst driving the growth of the blood collection market. As medical interventions have become increasingly advanced and accessible, the need for efficient and safe blood collection solutions has grown to support pre-operative diagnostics, intraoperative monitoring, and post-operative care. For instance, according to the National Library of Medicine, approximately 310 million major surgeries are conducted worldwide each year, with an estimated 40 to 50 million occurring in the U.S. and 20 million in Europe, thereby strengthening the critical role of blood collection in modern healthcare.
 

Blood collection is the process of collecting blood samples from a patient for diagnostic, therapeutic, or research purposes. Blood is collected through venous or capillary methods, depending on the volume required and the type of test. The procedure involves using various tools and devices, such as needles, syringes, lancets, blood collection tubes, and automated systems, to ensure safe, sterile, and accurate sample acquisition. 
 

Blood Collection Market Trends

With the growing aging population, there is an increasing need for diagnostic procedures to detect age-related conditions, many of which require blood collection for accurate diagnosis.
 

• For instance, according to the World Health Organization (WHO), by 2030 the population of individuals belonging to the age group of 60 years will reach 1.4 billion from 1 billion in 2020; further, the population of this age group will reach 2.1 billion by 2050. Moreover, by 2050, two-thirds of this population will be a part of middle- and low-income countries.
   
• This rising aging population stimulates the need for advanced blood collection devices to diagnose age-related conditions, thereby promoting market growth.
   
• Moreover, the expanding geriatric population base is emerging as a key force driving the growth of the global market. As aging is strongly associated with increased susceptibility to a range of chronic illnesses such as cardiovascular diseases, cancer, diabetes, renal disorders, and neurodegenerative conditions.
   
• Therefore, the steady rise in the elderly population globally is contributing to a growing demand for advanced healthcare services, particularly diagnostics and disease monitoring. Thus, the increasing incidence of age-related conditions, higher surgical intervention rates, and the shift towards home-based and preventive care have created an urgent need for innovative blood collection solutions that are safe, efficient, and tailored to meet the needs of geriatric patients.
   

Blood Collection Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market was valued at USD 8.8 billion in 2021. The market size reached USD 9.7 billion in 2023, from USD 9.2 billion in 2022.
 

Based on the product type, the market is segmented into system and consumables. The consumables segment accounted for 76.7% of the market in 2024 due to their precise sample collection and ability to support various types of blood tests. The segment is expected to exceed USD 13.9 billion by 2034, growing at a CAGR of 6% during the forecast period. On the other hand, the system segment is expected to grow with a CAGR of 6.3% from 2025 to 2034. The growth of this segment can be attributed to the rising demand for systems that improve efficiency, reduce contamination risks, and enhance patient comfort. As healthcare professionals seek faster and safer ways to collect blood samples, these systems are becoming an essential part of the modern diagnostic workflows.
 

• Consumables used in blood collection play an important role in the accuracy and reliability of diagnostic tests. Single-use items such as needles, syringes, and lancets further enhance safety by minimizing the risk of infection and cross-contamination.
   
• In addition, tubes containing specific additives such as EDTA, heparin, or citrate are specifically designed to preserve the chemical composition of blood samples, which helps in preventing degradation and maintaining the stability of blood components for various analysis.
   
• For instance, the VACUETTE K3EDTA Tube from Greiner Bio-One, which contains a precisely measured EDTA additive and is optimized for use with automated hematology systems, ensuring consistent and reliable results.
   
• Further, to streamline the blood collection process and minimize the errors, many consumables are pre-labeled and color-coded. For instance, the color of the tube cap indicates the type of additive inside it, which guides healthcare providers to select the appropriate tube for a specific test. Thus, these significantly improve workflow efficiency and diagnostic accuracy, which contribute to the segmental growth.
   

Based on the method, the blood collection market is segmented into manual blood collection and automated blood collection. The manual blood collection segment accounted for the highest market share of 53.2% in 2024 due to their ease of use, widespread availability, and lower cost, especially in resource-limited settings.
 

• Manual blood collection remains a fundamental technique in the healthcare industry, which relies on the skill and precision of healthcare professionals to accurately draw blood samples. This method involves the use of various devices designed to ensure efficiency, safety, and patient comfort.
   
• This process typically begins with selecting appropriate equipment, such as needles and vacuum-tube systems, tailored to the patient's needs and the type of sample required.
   
• Further, technological innovations have significantly enhanced the manual blood collection process. For example, BD’s PrecisionGlide needles feature thin-wall, three-sided tip technology that enables smoother insertion and reduces patient discomfort.
   
• Moreover, vacuum-tube systems are another critical component, designed to efficiently collect and transport blood samples while preserving sample integrity. This combination of advanced needle designs and reliable vacuum systems makes manual blood collection a dependable and effective method for diagnostic testing, thus significantly contributing to the growth of the market.
   
• On the other hand, the market for automated blood collection is rapidly transforming the blood collection landscape through the integration of advanced technologies that enhance efficiency, safety, and standardization.
   
• These systems are particularly valuable in high-volume clinical and blood bank environments, where procedures such as apheresis, component separation, and robotic venipuncture are increasingly common. For instance, in 2023, 11.6 million units of whole blood and apheresis RBCs were collected, and 11.3 million were transfused in 2021, highlighting the growing shift toward automation in blood collection practices.
   

Based on application, the blood collection market is segmented into diagnostics, treatment, and research. The diagnostics segment accounted for the highest market share of 50.6% in 2024 due to the increasing number of diagnostic procedures requiring blood samples, including disease screenings and chronic condition monitoring such as diabetes, cardiovascular diseases, and cancer.
 

• The growth of the segment is highly attributed due to the growing prevalence of chronic conditions such as diabetes, cardiovascular diseases, and cancer, significantly accelerating the demand of the advanced blood collection system.
   
• For instance, the International Diabetes Federation, approximately 589 million adults aged 20-79 years were living with diabetes in 2024, and this number is projected to surge 853 million by 2050.
   
• Therefore, as the prevalence of these diabetes conditions increases, so does the need for diagnostic tools such as needles, syringes, blood collection tubes, lancets, which plays a crucial role in detection and diagnosis of the diseases, thereby fostering the growth of the segment.
   
• Moreover, technological advancements are reshaping the diagnostic workflows. The integration of automated blood collection systems, capillary micro-sampling devices, and digital diagnostic platforms are improving the sample accuracy, minimizing the turnaround times, and enhancing patient comfort, thus accelerating the market growth.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the blood collection market is segmented into hospitals and clinics, diagnostic centers, blood banks, and academic and research institutes. The hospitals and clinics segment accounted for the highest market share of 37.2% in 2024 due to their role as primary healthcare providers, managing a high number of patients requiring routine blood tests, emergency diagnostics, and pre- and post-operative assessments.
 

• The increasing number of hospitals and clinics both in the developing and developed countries, stimulated by the factors such as growing population, increasing prevalences of chronic diseases, and advancement in the blood collection technologies, all together propelling the demand for advanced blood collection devices and system in the newly established hospital and clinics and as well in the existing hospital setting.
   
• Moreover, the rising healthcare infrastructure especially in the developing regions such Middle East and Africa and Asia Pacific is boosting the adoption of advanced technology pertaining to blood collection in the hospital settings.
   
• For instance, the UK's Department of Health and Social Care spending around EURO 15 million from its Official Development Assistance (ODA) budget in order to expand the healthcare infrastructure in the countries such as Kenya, Ghana, and Nigeria, this investment is spanning from the year 2022-25, with a major aim to expand the healthcare infrastructure and medical workforce in these African countries.  
   
• Thus, such investment in healthcare infrastructure is anticipated to propel the adoption of advanced blood collection systems in the hospitals and clinics.
   

Looking for region specific data?

Download Free PDF

The North America blood collection market dominated the global market with a market share of 35.4% in 2024. The market is driven by rising incidence of chronic diseases and growing demand for diagnostic services. Advancements in blood collection technology and a growing focus on early and accurate diagnosis also support market growth.
 

The U.S. market was valued at USD 2.8 billion and USD 2.9 billion in 2021 and 2022, respectively. The market size reached USD 3.2 billion in 2024, growing from USD 3.1 billion in 2023.
 

• This growth is largely attributed due to the rising prevalence of chronic conditions such as cardiovascular diseases, cancer, and diabetes across the country.
   
• For instance, in 2021, as per the data from the Centers for Disease Control and Prevention (CDC) approximately 38.4 million individuals across the U.S. had diabetes which is equivalent to 11.6% of the total population. Furthermore, between 2021-2023, around 47.7% of adult population including older individuals were diagnosed with hypertension across the U.S.
   
• Thus, the growing prevalence of chronic conditions in the country, underscoring the need for advance medical diagnostics, including the blood collection tools which are essential for accurate and timely disease detection. This growing demand is significantly contributing to the expansion of market.
   

Europe blood collection market accounted for USD 2.9 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising prevalence of chronic diseases in the region coupled with the increasing government initiatives to enhance healthcare infrastructure is anticipated to spur the growth of the market.
   
• Moreover, the presence of key market players in the region reinforces Europe’s strength in the market. These companies are actively participating in innovation through the development of innovative solutions, thereby aiding the market growth.
   

Germany blood collection market is anticipated to witness considerable growth over the analysis period.
 

• The rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes in the country is significantly influencing the growth of the market.
   
• For instance, according to data from the World Heart Federation, premature mortality due to cardiovascular disease (CVD) in Germany, death occurring between the ages of 30 and 70 accounts for 4% of total deaths. Among these, 56.6% are male and 60.5% are female. Additionally, a significant proportion of the adult population in Germany has raised total cholesterol levels, indicating a notable risk factor contributing to the national CVD burden.  
   
• Thus, as the number of cardiovascular disease (CVD) in the country increase, so does the need for advanced diagnostic tools, including blood collection devices. These devices play a critical role in early detection, monitoring, and management of CVD, thereby driving significant growth of the market in Germany.
   

The Asia Pacific blood collection market is anticipated to grow at the CAGR of 6.5% during the analysis timeframe.
 

• The market in the Asia Pacific region is expanding rapidly due to the growing burden of chronic diseases, rising health awareness, and continuous advancements in blood collection tools.
   
• Countries such as China, India and Japan are adopting advanced technology driven by the growing demand for advanced diagnostic solutions and expanding access to healthcare services.
   
• Additionally, rapid growth in the number of hospitals and diagnostic centers along with government policies aimed at improving diagnostic capabilities is further contributing to the growth of the market in the region.
   

China blood collection market is predicted to grow significantly over the forecast period.
 

• The country is experiencing one of speediest aging population, which necessitates frequent health monitoring.
   
• For instance, as per the estimates from the World Health Organization in 2019, approximately 254 million people of age group 65 and above were residing in the country. This number is projected to rise significantly, with 402 million people expected to be over the age of 60 by 2040.
   
• The individuals of these age group are at high risk of developing chronic health condition such as cancer, diabetes, cardiovascular diseases, among others. This growing elderly population necessitates the use of advanced diagnostic tools particularly blood collection devices to ensure timely, accurate, and effective disease detection and management, thereby fueling the growth of the market.
   

Brazil is experiencing significant growth in the Latin America blood collection market due to the increasing demand for advanced diagnostic solutions.
 

• The rising prevalence of chronic diseases such as cardiovascular diseases, neurological disorders, and others are contributing to the growth of the market.
   
• For instance, according to the Brazilian National Health Survey in 2019, there were approximately 12.95 million individuals diagnosed with cardiovascular disease (CVD) in Brazil, with 51% of the affected population being male.
   
• Additionally, there has been growing awareness about the benefits of early disease detection and prevention, driven by public health initiatives and education campaigns encouraging individuals to undergo health check-ups. This trend is expected to foster market growth.
   

Saudi Arabia blood collection market is poised to witness substantial growth in the Middle East and Africa market during the forecast period.
 

• The government of Saudi Arabia is significantly investing in the healthcare infrastructure, to incorporate advanced medical devices such blood collection systems within the hospitals setting to provide utmost care to the individuals suffering from the chronic condition in the country.
   
• According to the Saudi Ministry of Health, in 2023, the government had allocated around USD 50.4 billion budget for healthcare infrastructure and social development.
   
• Such investments are anticipated to enhance the accessibility and quality of medical services, among the individuals of the country, thereby accelerating market growth.
   

Blood Collection Market Share

• The top 5 players such as Becton, Dickinson, and Company (BD), McKesson Corporation, Fresenius SE & Co, Nipro Corporation, and Cardinal Health together hold 35.8% of the market share in the fragmented global market. These businesses keep their dominance by combining strong product lines, business alliances, legal clearances, and continuous innovation.  
   
• BD remains a dominant force in the market, leveraging its expansive diagnostic solutions and blood collection systems. The company’s strategic restructuring under the “BD 2025” initiative aims to sharpen its focus on high-growth medtech segments, including blood collection, where it continues to lead with innovations such as the BD Vacutainer system and the MiniDraw capillary collection device.
   
• Companies in the market are adopting competitive pricing strategies to expand their reach, particularly in emerging economies where affordability is key to market penetration. Leading players are also addressing unmet needs by introducing advanced blood collection systems which are designed for high-volume sampling and minimal patient discomfort. For example, manufacturers are developing vacuum-based and capillary blood collection devices which enhanced safety features, such as needle-stick prevention and contamination control, to meet evolving clinical standards. These innovations are especially important in managing chronic disease and large-scale diagnostic programs, where frequent and reliable blood sampling is necessary.
   
• Emerging trends in the market include the development of high-volume blood collection systems, integration of digital tracking for sample integrity, and the expansion of home-based blood collection kits. These innovations are being driven by the increasing demand for chronic disease diagnostics, personalized medicine, and decentralized healthcare delivery.
   

Blood Collection Market Companies

Some of the eminent market participants operating in the blood collection industry include:

• Abbott Laboratories
• Becton, Dickinson, and Company
• Cardinal Health
• F. Hoffmann-La Roche
• FL MEDICAL
• Fresenius SE & Co
• Greiner
• Haemonetics Corporation
• McKesson Corporation
• Nipro Corporation
• QIAGEN
• Sarstedt AG & Co
• Siemens Healthineers
• Streck
• Terumo Corporation
• Thermo Fisher Scientific
   
• Becton, Dickinson, and Company (BD)

BD’s centers on its engineering expertise and patient centric innovation. The company’s FDA cleared MiniDraw capillary blood collection system, enables lab quality testing from fingertip samples, offering a less invasive alternative to traditional venous draw. BD also leads with its Vacutainer range, a gold standard in specimen management, reinforcing its dominance in clinical diagnostics.
 

• Terumo Corporation

Terumo stands out with its global reach and advanced blood collection technologies. The company offers a comprehensive portfolio of high-quality blood bags with advanced donor safety features, sterile docking options, and biocompatible materials. With over 30,000 employees worldwide, Terumo leverages its scale to drive innovation and deliver reliable solutions across hospitals and blood centers.
 

• McKesson Corporation

McKesson’s broad distribution network and safety-focused product line are its key significations. Through its McKesson Brand, the company offers a wide range of blood collection sets, transfer devices, and specimen containers designed for safety and efficiency. Products such as the McKesson Prevent G Blood Collection Set feature needle-stick prevention without altering workflow, making them ideal for high-volume clinical environments.
 

Blood Collection Industry News

• In June 2024, Streck launched the Protein Plus BCT, a direct-draw whole blood collection tube designed to preserve sample integrity during storage, shipping, and handling. The tube features a preservative reagent that reduces ex vivo hemolysis and platelet activation, minimizes interference from proteins released by blood cells, and helps maintain draw-time concentrations of plasma proteins during ambient temperature storage. This product launch strengthened the company’s overall product portfolio.
   
• In December 2024, BD and Babson Diagnostics expanded their fingertip blood collection technology across the U.S. healthcare settings. By integrating BD’s MiniDraw system with Babson’s BetterWay platform, they enabled accurate lab-quality results from just six drops of capillary blood, strengthening BD’s leadership in minimally invasive, patient-centric diagnostics.
   
• In December 2024, NAMSA, a global medtech Contract Research Organization (CRO) focused on end-to-end market access services, formed a strategic outsourcing partnership with Terumo. The collaboration is aimed at supporting the regulatory approval and commercialization of Terumo’s product portfolio. This partnership, expected to enable a more streamlined and efficient entry of Terumo’s products into global markets.
   

The blood collection market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• System
  • Automated systems 
  • Manual systems
• Consumables
  • Venous
    • Needles and syringes
      • Double-ended needles       
      • Winged blood collection sets
      • Standard hypodermic needles
      • Other blood collection needles      
    • Blood collection tubes
      • Serum-separating
      • EDTA
      • Heparin        
      • Plasma-separating
    • Blood bags
    • Other venous products
  • Capillary
    • Lancets
    • Micro-container tubes
    • Micro-hematocrit tubes
    • Warming devices
    • Other capillary products

Market, By Method

• Manual blood collection
• Automated blood collection

Market, By Application

• Diagnostics
• Treatment
• Research

Market, By End Use

• Hospitals and clinics
• Diagnostic centers
• Blood banks
• Academic and research institutes

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE